215 related articles for article (PubMed ID: 29555484)
1. Patient-reported Outcomes and Quality of Life After Treatment of Choroidal Melanoma: A Comparison of Enucleation Versus Radiotherapy in 1596 Patients.
Damato B; Hope-Stone L; Cooper B; Brown SL; Salmon P; Heimann H; Dunn LB
Am J Ophthalmol; 2018 Sep; 193():230-251. PubMed ID: 29555484
[TBL] [Abstract][Full Text] [Related]
2. Quality of life after iodine 125 brachytherapy vs enucleation for choroidal melanoma: 5-year results from the Collaborative Ocular Melanoma Study: COMS QOLS Report No. 3.
Melia M; Moy CS; Reynolds SM; Hayman JA; Murray TG; Hovland KR; Earle JD; Kurinij N; Dong LM; Miskala PH; Fountain C; Cella D; Mangione CM;
Arch Ophthalmol; 2006 Feb; 124(2):226-38. PubMed ID: 16476893
[TBL] [Abstract][Full Text] [Related]
3. Combined plaque radiotherapy and transpupillary thermotherapy in choroidal melanoma: 5 years' experience.
Bartlema YM; Oosterhuis JA; Journée-De Korver JG; Tjho-Heslinga RE; Keunen JE
Br J Ophthalmol; 2003 Nov; 87(11):1370-3. PubMed ID: 14609837
[TBL] [Abstract][Full Text] [Related]
4. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19.
Jampol LM; Moy CS; Murray TG; Reynolds SM; Albert DM; Schachat AP; Diddie KR; Engstrom RE; Finger PT; Hovland KR; Joffe L; Olsen KR; Wells CG;
Ophthalmology; 2002 Dec; 109(12):2197-206. PubMed ID: 12466159
[TBL] [Abstract][Full Text] [Related]
5. [Quality of life in patients with choroidal melanoma].
Blanco-Rivera C; Capeáns-Tomé C; Otero-Cepeda XL
Arch Soc Esp Oftalmol; 2008 May; 83(5):301-6. PubMed ID: 18464179
[TBL] [Abstract][Full Text] [Related]
6. Comparison between patient-reported outcomes after enucleation and proton beam radiotherapy for uveal melanomas: a 2-year cohort study.
Hope-Stone L; Brown SL; Heimann H; Damato B
Eye (Lond); 2019 Sep; 33(9):1478-1484. PubMed ID: 30988421
[TBL] [Abstract][Full Text] [Related]
7. Ruthenium-106 versus iodine-125 plaque brachytherapy of 571 choroidal melanomas with a thickness of ≥5.5 mm.
Filì M; Trocme E; Bergman L; See TRO; André H; Bartuma K; Girnita L; All-Eriksson C; Seregard S; Stålhammar G
Br J Ophthalmol; 2020 Jan; 104(1):26-32. PubMed ID: 30910871
[TBL] [Abstract][Full Text] [Related]
8. Endoresection technique with/without brachytherapy for management of high posterior choroidal melanoma: extended follow-up results.
Garcia-Arumi J; Leila M; Zapata MA; Velázquez D; Dinares-Fernandez MC; Tresserra F; Corcostegui B
Retina; 2015 Apr; 35(4):628-37. PubMed ID: 25462434
[TBL] [Abstract][Full Text] [Related]
9. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
[TBL] [Abstract][Full Text] [Related]
10. Quality of life assessment in the collaborative ocular melanoma study: design and methods. COMS-QOLS Report No. 1. COMS Quality of Life Study Group.
Ophthalmic Epidemiol; 1999 Mar; 6(1):5-17. PubMed ID: 10384680
[TBL] [Abstract][Full Text] [Related]
11. Quality of life and cancer-related needs in patients with choroidal melanoma.
Wiley JF; Laird K; Beran T; McCannel TA; Stanton AL
Br J Ophthalmol; 2013 Nov; 97(11):1471-4. PubMed ID: 24037609
[TBL] [Abstract][Full Text] [Related]
12. Survival following enucleation versus plaque radiotherapy in statistically matched subgroups of patients with choroidal melanomas: results in patients treated between 1980 and 1987.
Augsburger JJ; Schneider S; Freire J; Brady LW
Graefes Arch Clin Exp Ophthalmol; 1999 Jul; 237(7):558-67. PubMed ID: 10424306
[TBL] [Abstract][Full Text] [Related]
13. [Choroid melanoma. A retrospective randomized comparative study of ruthenium irradiation vs enucleation].
Guthoff R; Frischmuth J; Jensen OA; Bjerrum K; Prause JU
Klin Monbl Augenheilkd; 1992 Apr; 200(4):257-61. PubMed ID: 1614086
[TBL] [Abstract][Full Text] [Related]
14. Endoresection versus iodine-125 plaque brachytherapy for the treatment of choroidal melanoma.
Caminal JM; Mejia K; Masuet-Aumatell C; Arias L; Piulats JM; Gutierrez C; Pera J; Catala J; Rubio M; Arruga J
Am J Ophthalmol; 2013 Aug; 156(2):334-342.e1. PubMed ID: 23677135
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of disease-specific measures for choroidal melanoma: COMS-QOLS report No. 2.
Melia M; Moy CS; Reynolds SM; Cella D; Murray TG; Hovland KR; Hayman JA; Mangione CM;
Arch Ophthalmol; 2003 Jul; 121(7):1010-20. PubMed ID: 12860806
[TBL] [Abstract][Full Text] [Related]
16. Quality of life: fractionated stereotactic radiotherapy versus enucleation treatment in uveal melanoma patients.
van Beek JGM; Buitendijk GHS; Timman R; Muller K; Luyten GPM; Paridaens D; Naus NC; Kiliç E
Acta Ophthalmol; 2018 Dec; 96(8):841-848. PubMed ID: 30284368
[TBL] [Abstract][Full Text] [Related]
17. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
[TBL] [Abstract][Full Text] [Related]
18. Survival implications of enucleation after definitive radiotherapy for choroidal melanoma: an example of regression on time-dependent covariates.
Egan KM; Ryan LM; Gragoudas ES
Arch Ophthalmol; 1998 Mar; 116(3):366-70. PubMed ID: 9514491
[TBL] [Abstract][Full Text] [Related]
19. Psychological reactions and quality of life in patients with posterior uveal melanoma treated with ruthenium plaque therapy or enucleation: a one year follow-up study.
Brandberg Y; Kock E; Oskar K; af Trampe E; Seregard S
Eye (Lond); 2000 Dec; 14(Pt 6):839-46. PubMed ID: 11584839
[TBL] [Abstract][Full Text] [Related]
20. Quality of life in the follow-up of uveal melanoma patients after enucleation in comparison to CyberKnife treatment.
Klingenstein A; Fürweger C; Mühlhofer AK; Leicht SF; Schaller UC; Muacevic A; Wowra B; Hintschich C; Eibl KH
Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):1005-12. PubMed ID: 26573389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
